Abstract
Peripartum cardiomyopathy (PPCM) is a rare disease of unclear etiology with a frequent poor outcome, despite optimal medical therapy. Recent experimental data implicate a causal role of prolactin. We report a patient with PPCM who responded well to treatment with Bromocriptine in addition to standard therapy of heart failure.
MeSH terms
-
Adult
-
Bromocriptine / pharmacology
-
Bromocriptine / therapeutic use*
-
Cardiomyopathies / drug therapy*
-
Cardiomyopathies / metabolism
-
Cathepsin D / metabolism
-
Female
-
HELLP Syndrome*
-
Heart Failure / drug therapy*
-
Heart Failure / metabolism
-
Hormone Antagonists / pharmacology
-
Hormone Antagonists / therapeutic use*
-
Humans
-
Myocardium / metabolism
-
Pregnancy
-
Pregnancy Complications, Cardiovascular / drug therapy*
-
Pregnancy Complications, Cardiovascular / metabolism
-
Prolactin / antagonists & inhibitors
Substances
-
Hormone Antagonists
-
Bromocriptine
-
Prolactin
-
Cathepsin D